Compare KLRA & STDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KLRA | STDN |
|---|---|---|
| Founded | 2024 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2026 | 2026 |
| Metric | KLRA | STDN |
|---|---|---|
| Price | $11.57 | $8.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $43.00 | $16.88 |
| AVG Volume (30 Days) | ★ 780.6K | 251.9K |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $460.20 |
| Revenue Next Year | N/A | $249.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.76 | $7.05 |
| 52 Week High | $23.82 | $17.34 |
| Indicator | KLRA | STDN |
|---|---|---|
| Relative Strength Index (RSI) | 40.01 | 30.24 |
| Support Level | $9.76 | $7.05 |
| Resistance Level | $11.81 | $13.61 |
| Average True Range (ATR) | 1.01 | 1.05 |
| MACD | -0.18 | -0.34 |
| Stochastic Oscillator | 5.26 | 3.12 |
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.
Standard Nuclear Inc is an independent advanced nuclear fuel company. The company designs, engineers, and manufactures advanced nuclear fuels, with a primary focus on TRISO fuel for advanced reactors. Its operations include industrial-scale TRISO fuel manufacturing and the development of fuel for advanced reactors that utilize TRISO fuel. The company operates in a single operating and reportable segment, as it is engaged in a single business activity of TRISO production. It derives revenue from fuel development and services agreements. Geographically, the maximum revenue is generated from the United States.